b-One Biotechnology (SH) Co., Ltd. – Trademark Portfolio

Entity Type: 16

b-One Biotechnology (SH) Co., Ltd. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. Currently, 2 trademarks are registered. Notable registered marks include MOBIO and JUVENO. The owner is based in Shanghai.

Room 108, No.26 Jiafeng Road

China (Shanghai) Pilot Free Trade Zone

Shanghai 202150 , CN

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

JUVENO
JUVENO
Registered 2018
FRETELLA
FRETELLA
Abandoned 2018
BALANSEE
BALANSEE
Abandoned 2018
MOBIO
MOBIO
Registered 2018

Trademark Classifications

b-One Biotechnology (SH) Co., Ltd.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (4 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does b-One Biotechnology (SH) Co., Ltd. have?

b-One Biotechnology (SH) Co., Ltd. has 4 U.S. trademarks filed with the USPTO. Of these, 2 registered, 2 abandoned.

What trademark classes does b-One Biotechnology (SH) Co., Ltd. file in?

b-One Biotechnology (SH) Co., Ltd. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are b-One Biotechnology (SH) Co., Ltd.'s most well-known trademarks?

b-One Biotechnology (SH) Co., Ltd.'s registered trademark portfolio includes well-known marks such as MOBIO and JUVENO. These are among 2 currently registered trademarks in the portfolio.

What is b-One Biotechnology (SH) Co., Ltd.'s trademark registration success rate?

b-One Biotechnology (SH) Co., Ltd. has a 50% trademark registration rate, with 2 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.